Perioperative detection of circulating tumour cells in patients with lung cancer

被引:20
|
作者
Chudasama, Dimple [1 ,3 ]
Burnside, Nathan [1 ]
Beeson, Julie [1 ]
Karteris, Emmanouil [3 ]
Rice, Alexandra [2 ]
Anikin, Vladimir [1 ]
机构
[1] Royal Brompton & Harefield Trust, Harefield Hosp, Dept Cardiothorac Surg, Hill End Rd, Harefield UB9 6JH, Middx, England
[2] Royal Brompton & Harefield Trust, Harefield Hosp, Dept Pathol, Harefield UB9 6JH, Middx, England
[3] Brunel Univ London, Dept Life Sci, Uxbridge UB8 3PH, Middx, England
关键词
circulating tumour cells; lung cancer; diagnosis; METASTATIC BREAST-CANCER; PROGNOSTIC-FACTOR; PROGRESSION-FREE; SURVIVAL; BLOOD;
D O I
10.3892/ol.2017.6366
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer is a leading cause of mortality and despite surgical resection a proportion of patients may develop metastatic spread. The detection of circulating tumour cells (CTCs) may allow for improved prediction of metastatic spread and survival. The current study evaluates the efficacy of the ScreenCell (R) filtration device, to capture, isolate and propagate CTCs in patients with primary lung cancer. Prior to assessment of CTCs, the present study detected cancer cells in a proof-of-principle-experiment using A549 human lung carcinoma cells as a model. Ten patients (five males and five females) with pathologically diagnosed primary non-small cell lung cancer undergoing surgical resection, had their blood tested for CTCs. Samples were taken from a peripheral vessel at the baseline, from the pulmonary vein draining the lobe containing the tumour immediately prior to division, a further central sample was taken following completion of the resection, and a final peripheral sample was taken three days post-resection. A significant increase in CTCs was observed from baseline levels following lung manipulation. No association was able to be made between increased levels of circulating tumour cells and survival or the development of metastatic deposits. Manipulation of the lung during surgical resection for non-small cell lung carcinoma results in a temporarily increased level of CTCs; however, no clinical impact for this increase was observed. Overall, the study suggests the ScreenCell (R) device has the potential to be used as a CTC isolation tool, following further work, adaptations and improvements to the technology and validation of results.
引用
收藏
页码:1281 / 1286
页数:6
相关论文
共 50 条
  • [1] MOLECULAR CHARACTERISTICS OF CIRCULATING TUMOUR CELLS AND CIRCULATING TUMOUR MICROEMBOLI IN PATIENTS WITH LUNG CANCER
    Hou, Jian-Mei
    Krebs, Matt
    Ward, Tim
    Sloane, Robert
    Priest, Lynsey
    Blackhall, Fiona
    Dive, Caroline
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S670 - S670
  • [2] Detection of Circulating Tumour Cells and Survival of Patients with Non-small Cell Lung Cancer
    Chudasama, Dimple
    Barr, James
    Beeson, Julie
    Beddow, Emma
    Mcgonigle, Niall
    Rice, Alexandra
    Nicholson, Andrew
    Anikin, Vladimir
    [J]. ANTICANCER RESEARCH, 2017, 37 (01) : 169 - 173
  • [3] THE DETECTION OF CIRCULATING TUMOR CELLS IN LUNG CANCER PATIENTS
    Klein, J.
    Srovnal, J.
    Kolar, Z.
    Skarda, J.
    Skalicky, P.
    Janaskova, T.
    Hajduch, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S43 - S43
  • [4] Circulating tumour cells in patients with lung cancer undergoing endobronchial cryotherapy
    Chudasama, Dimple
    Rice, Alexandra
    Soppa, Gopal
    Anikin, Vladimir
    [J]. CRYOBIOLOGY, 2015, 71 (01) : 161 - 163
  • [5] Perioperative detection of circulating cancer cells in patients with colorectal hepatic metastases
    Uchikura, K
    Ueno, S
    Takao, S
    Miyazono, F
    Nakashima, S
    Tokuda, K
    Nakajo, A
    Matsumoto, M
    Aiko, T
    [J]. HEPATO-GASTROENTEROLOGY, 2002, 49 (48) : 1611 - 1614
  • [6] Methods for Detection of Circulating Tumour Cells and Their Clinical Value in Cancer Patients
    Mikulova, V.
    Kolostova, K.
    Zima, T.
    [J]. FOLIA BIOLOGICA, 2011, 57 (04) : 151 - 161
  • [7] Detection and clinical significance of circulating tumour cells in patients with rectal cancer
    Dong, S.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [8] Tumour molecular profiling and quantitative detection of circulating biomarkers in patients with lung cancer
    Karampini, E.
    Farah, H.
    Mills, G.
    Kamal, N.
    Tobal, K.
    Cane, P.
    Muirhead, J.
    Pomplun, S.
    King, J. E.
    Sethi, T.
    McCaughan, F.
    Spicer, J.
    [J]. LUNG CANCER, 2015, 87 : S3 - S4
  • [9] Circulating tumour cells from small cell lung cancer patients are tumourigenic
    Hodgkinson, C.
    Morrow, C.
    Tugwood, J.
    Li, Y.
    Metcalf, R.
    Rothwell, D.
    Trapani, F.
    Burt, D.
    Simpson, K.
    Morris, K.
    Pepper, S.
    Nonake, D.
    Greystoke, A.
    Kelly, P.
    Bola, B.
    Polanski, R.
    Krebs, M.
    Antonello, J.
    Ayub, M.
    Faulkner, S.
    Priest, L.
    Carter, L.
    Tate, C.
    Miller, C.
    Blackhall, F.
    Brady, G.
    Dive, C.
    [J]. LUNG CANCER, 2015, 87 : S1 - S1
  • [10] The Presence of Circulating Tumour Cells is a Negative Prognostic Factor in Lung Cancer Patients
    Benedikova, A.
    Srovnal, J.
    Klein, J.
    Skalicky, P.
    Szkorupa, M.
    Cahova, D.
    Hajduch, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S187 - S188